CoChat

Mortality indicators in pneumococcal meningitis: therapeutic implications

Open access
Erdem, Hakan, Elaldi, Nazif, Öztoprak, Nefise, Sengoz, Gonul, Ak, Oznur, Kaya, Selcuk, Inan, Asuman, Nayman-Alpat, Saygın, Ulu-Kilic, Ayşegül, Pekok, Abdullah Umut, Gunduz, Alper, Gozel, Mustafa G., Pehlivanoglu, Filiz, Yasar, Kadriye, Yılmaz, Hava, Hatipoglu, Mustafa, Cicek-Senturk, Gonul, Akcam, Fusun Z., Inkaya, Ahmet C., Kazak, Esra, Sagmak-Tartar, Ayşe, Tekin, Recep, Ozturk-Engin, Derya, Ersoy, Yasemin, Sipahi, Oguz Resat, Guven, Tumer, Tuncer-Ertem, Gunay, Alabay, Selma, Akbulut, Ayhan, Balkan, Ilker I., Oncul, Oral, Cetin, Birsen, Dayan, Saim, Ersoz, Gulden, Karakas, Ahmet, Ozgunes, Nail, Sener, Alper, Yesilkaya, Aysegul, Erturk, Ayse, Gundes, Sibel, Karabay, Oguz, Sirmatel, Fatma, Tosun, Selma, Turhan, Vedat, Yalci, Aysun, Akkoyunlu, Yasemin, Aydın, Emsal, Diktas, Husrev, Kose, Sukran, Ulcay, Asim, Seyman, Derya, Savasci, Umit, Leblebicioglu, Hakan, Vahaboglu, Haluk · 2014 · International Journal of Infectious Diseases
Cited by 49

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The aim of this study was to delineate mortality indicators in pneumococcal meningitis with special emphasis on therapeutic implications. METHODS: This retrospective, multicenter cohort study involved a 15-year period (1998-2012). Culture-positive cases (n=306) were included solely from 38 centers. RESULTS: Fifty-eight patients received ceftriaxone plus vancomycin empirically. The rest were given a third-generation cephalosporin alone. Overall, 246 (79.1%) isolates were found to be penicillin-susceptible, 38 (12.2%) strains were penicillin-resistant, and 22 (7.1%) were oxacillin-resistant (without further minimum inhibitory concentration testing for penicillin). Being a critical case (odds ratio (OR) 7.089, 95% confidence interval (CI) 3.230-15.557) and age over 50 years (OR 3.908, 95% CI 1.820-8.390) were independent predictors of mortality, while infection with a penicillin-susceptible isolate (OR 0.441, 95% CI 0.195-0.996) was found to be protective. Empirical vancomycin use did not provide significant benefit (OR 2.159, 95% CI 0.949-4.912). CONCLUSIONS: Ceftriaxone alone is not adequate in the management of pneumococcal meningitis due to penicillin-resistant pneumococci, which is a major concern worldwide. Although vancomycin showed a trend towards improving the prognosis of pneumococcal meningitis, significant correlation in statistical terms could not be established in this study. Thus, further studies are needed for the optimization of pneumococcal meningitis treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijid.2013.09.012

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 49

Metadata

Authors
Erdem, H., Elaldi, N., Öztoprak, N., Sengoz, G., Ak, O., Kaya, S., Inan, A., Nayman-Alpat, S., Ulu-Kilic, A., Pekok, A. U., Gunduz, A., Gozel, M. G., Pehlivanoglu, F., Yasar, K., Yılmaz, H., Hatipoglu, M., Cicek-Senturk, G., Akcam, F. Z., Inkaya, A. C., Kazak, E., Sagmak-Tartar, A., Tekin, R., Ozturk-Engin, D., Ersoy, Y., Sipahi, O. R., Guven, T., Tuncer-Ertem, G., Alabay, S., Akbulut, A., Balkan, I. I., Oncul, O., Cetin, B., Dayan, S., Ersoz, G., Karakas, A., Ozgunes, N., Sener, A., Yesilkaya, A., Erturk, A., Gundes, S., Karabay, O., Sirmatel, F., Tosun, S., Turhan, V., Yalci, A., Akkoyunlu, Y., Aydın, E., Diktas, H., Kose, S., Ulcay, A., Seyman, D., Savasci, U., Leblebicioglu, H., & Vahaboglu, H.
Venue
International Journal of Infectious Diseases
Publisher
Elsevier BV
Published
2014-02
Volume
19
Pages
13-19
ISSN
1201-9712 (ISSN-L)
OpenAlex
W2018166454
Cited by
49
References
3
FWCI
2.69
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mortality indicators in pneumococcal meningitis: therapeutic implications. https://app.cochat.ai/papers/10.1016/j.ijid.2013.09.012
The paper
Erdem, H., Elaldi, N., Öztoprak, N., Sengoz, G., Ak, O., Kaya, S., Inan, A., Nayman-Alpat, S., Ulu-Kilic, A., Pekok, A. U., Gunduz, A., Gozel, M. G., Pehlivanoglu, F., Yasar, K., Yılmaz, H., Hatipoglu, M., Cicek-Senturk, G., Akcam, F. Z., Inkaya, A. C., . . . Vahaboglu, H. (2014). Mortality indicators in pneumococcal meningitis: therapeutic implications. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2013.09.012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.